Meet the director

  • Boris Kantor
  • Assistant Research Professor of Neurobiology
  • Campus mail: DUMC Box 3209
  • Bryan Res Bldg, Durham, NC 27710
  • Phone: (919)-681-1068
  • Fax: (919)613-6750
  • Email address: Boris.Kantor@duke.edu

 

 

Education and Training

  • Department of Immunology at the Hebrew University of Jerusalem, Israel-M. Sc 1998
  • Department of Human Molecular Genetics at Hebrew University of Jerusalem, Israel- PhD 2004
  • Gene Therapy Center at University of North Carolina at Chapel Hill- Postdoctoral Fellowship 2009

Selective Publications:

  1. Vijayraghava S and Kantor B. A protocol for the production of Integrase-Deficient Lentiviral Vectors for CRISPR/Cas9-Mediated Gene Knockout in Dividing Cells (2017). JoVE. In-Press.
  2. Ortinski PI, O’Donovan B, Dong X,  and Kantor B. Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing (2017). Mol Ther Methods in Clin Dev (5) 153-164 (advanced online publication);  https://doi.org/10.1016/j.omtm.2017.04.002
  3. Kantor B, Lentz TB, Nagabhushan Kalburgi S, McCown TJ, and Gray, SJ. Advances in viral-mediated gene delivery (2014). Advances in Molecular Genetics; 2014; 87:125-97. doi: 10.1016/B978-0-12-800149-3.00003-2.2
  4. Kantor B, Nagabhushan Kalburgi S, McCown TJ, and Gray, SJ. Clinical Applications Involving CNS Gene Transfer (2014). Advances in Molecular Genetics; 2014; 87:71-124. doi: 10.1016/B978-0-12-800149-3.00002-0.
  5. Titus MA, Zeithaml B, Kantor B, Li X, Haack K, Moore DT, Wilson EM, Mohler1 JL, and Kafri T. Dominant-Negative Androgen Receptor Inhibition of Intracrine Androgen-Dependent Growth of Castration-Recurrent. Prostate Cancer (2012). PLoS One. 2012; 7(1):e30192. Epub 2012 Jan 17.
  6. Johnson JS, Gentzsch M, Zhang L, Ribeiro CM, Kantor B, Kafri T, Pickles RJ, Samulski RJ. AAV exploits sub-cellular stress associated with inflammation, endoplasmic reticulum expansion, and misfolded proteins in models of cystic fibrosis (2011). PLoS Pathog. Epub 2011 May 19. May; 7(5):e1002053. doi: 10.1371/journal.ppat.100035.
  7. Kantor B, Bayer M, Ma H, Samulski J, Li C, McCown T, Kafri T. Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector (2011). Mol Ther. 2011 Mar; 19(3):547-56.
  8. Monahan PE, Lothrop CD, Sun J, Hirsch ML, Kafri T, Kantor B, Sarkar R, Tillson DM, Elia JR, Samulski RJ. (2010). Proteasome inhibitors enhance gene delivery by AAV virus vectors expressing large genomes in hemophilia mouse and dog models: a strategy for broad clinical application. Mol. Ther. 18(11):1907-16. Epub Aug 10. 2010.
  9. Kantor B, Ma H, Webster-Cyriaque J, Monahan PE, Kafri T. Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection (2009). Proc Natl Acad Sci U S A. Nov 3; 106(44):18786-91.
  10. Bayer M, Kantor B, Cockrell A, Hong M, Zeithaml B, Li X, McCown, T, and Kafri T. A large U3 deletion causes increased in vivo expression from a nonintegrated lentiviral vector (2008). Molecular Therapy. Advance online publication 16 September 2008. doi: 10.1038/mt.2008.199.

 

Complete List of Published Work in My Bibliography:

http://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/44877492/